AtriCure, Inc.
ATRCCIK 0001323885 · last filing Jul 2, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
3,071 bought / 0 sold
net +3,071 sh · +$73.0K
- buys
- 5
- sells
- 0
- insiders active
- 5
Filing tape
Filed Thu, Jul 2, 2026
- +636 sh · $15.1K
Doraiswamy Vinayak — Chief Scientific Officer
- Granted636Common Stock@ $23.78→ 92,511 held
- +636 sh · $15.1K
Dahlquist Karl S. — Chief Legal Officer
- Granted636Common Stock@ $23.78→ 96,689 held
- +527 sh · $12.5K
Seith Douglas J — Chief Operating Officer
- Granted527Common Stock@ $23.78→ 229,867 held
- +636 sh · $15.1K
Privitera Salvatore — Chief Technical Officer
- Granted636Common Stock@ $23.78→ 158,684 held
- +636 sh · $15.1K
Carrel Michael H — President, CEO, & Director · Director
- Granted636Common Stock@ $23.78→ 779,134 held
Insiders on this tape
- Doraiswamy VinayakChief Scientific Officer
- Dahlquist Karl S.Chief Legal Officer
- Seith Douglas JChief Operating Officer
- Privitera SalvatoreChief Technical Officer
- Carrel Michael HPresident, CEO, & Director · Director
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.